| Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in Patients With Advanced Solid Tumors (NCT05204862) | TiumBio Co., Ltd. | 2021-12-02 |
| Efficacy and Safety of IBI110 in Combination With Sintilimab Versus Sintilimab Alone in Neoadjuvant and Adjuvant Therapy of Radically Resectable Non-small Cell Lung Cancer (NCT05088967) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-12-02 |
| A Comparative Study of Rupatadine 10 mg Tablets and Clarinex® 5 mg Tablets Under Fasting Conditions (NCT05356143) | J. Uriach and Company | 2021-12-02 |
| Study to Evaluate Safety and Tolerability of CC-91633 (BMS-986397) in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes (NCT04951778) | Celgene | 2021-12-02 |
| Evaluation of LBL-003 Phase I Study in Patients With Advanced Malignancies (NCT05042908) | Nanjing Leads Biolabs Co.,Ltd | 2021-12-02 |
| Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19 (NCT04934111) | MRC/UVRI and LSHTM Uganda Research Unit | 2021-12-02 |
| Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease (NCT04328714) | Edwin Horwitz | 2021-12-02 |
| Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery (NCT04391049) | NRG Oncology | 2021-12-02 |
| A Phase I Study of GZR18 Injection in Healthy Subjects (NCT06548997) | Gan and Lee Pharmaceuticals, USA | 2021-12-02 |
| SP16 as a Therapeutic for COVID-19 Induced ARDS (NCT05135624) | Serpin Pharma, LLC | 2021-12-01 |
| Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH (NCT05043181) | Tang-Du Hospital | 2021-12-01 |
| A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It Works (NCT05134987) | Novo Nordisk A/S | 2021-12-01 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics of ZX-7101A and the Food Effect in Healthy Volunteers (NCT05217732) | Nanjing Zenshine Pharmaceuticals | 2021-12-01 |
| Feasibility Trial of Pregnenolone for Posttraumatic Stress Disorder and Alcohol Use Disorder (NCT04464148) | University of Texas Southwestern Medical Center | 2021-12-01 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases (NCT05147688) | The Foundation for Orthopaedics and Regenerative Medicine | 2021-12-01 |
| the Effect of Preoperative Sodium Ibuprofen on Postoperative Endodontic Pain (NCT04964622) | Cairo University | 2021-12-01 |
| Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma (NCT04910022) | Nerviano Medical Sciences | 2021-12-01 |
| Immunotherapy With Dinutuximab Beta in Combination With Chemotherapy for the Treatment of Patients With Primary Neuroblastoma Refractory to Standard Therapy and With Relapsed or Progressive Disease (NCT05272371) | Jagiellonian University | 2021-12-01 |
| Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours (NCT05043714) | Akamis Bio | 2021-12-01 |
| Safety & Efficacy of AlloRx SC® in PTHS Patients (NCT05165017) | Vitro Biopharma Inc. | 2021-12-01 |
| A Study of ALG-055009 in Healthy Volunteers and Subjects With Hyperlipidemia (NCT05090111) | Aligos Therapeutics | 2021-12-01 |
| A Study to Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML) (NCT04887857) | Celgene | 2021-12-01 |
| The Safety, Tolerability and Immunogenicity of COVID-19 Vaccine (SCTV01C) in Healthy, Unvaccinated Adults (NCT05148091) | Sinocelltech Ltd. | 2021-12-01 |
| Effect of Menopausal Hormone Therapy on Immune System Parameters (NCT05678192) | Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare | 2021-12-01 |
| Safety, Tolerance and Pharmacokinetics of THR-1442 in Chinese Healthy Subjects (NCT05369078) | Newsoara Biopharma Co., Ltd. | 2021-12-01 |
| Redefining Survivorship: POWER to Maximize Physical Function for Survivors of Critical Illness (NCT04058977) | Kirby Mayer | 2021-12-01 |
| Abuse Potential and Human Pharmacology of Methylone (NCT05488171) | Germans Trias i Pujol Hospital | 2021-12-01 |
| Bioequivalence of Dotilavir Sodium Tablets in Healthy Subjects in the Fasting and Fed State (NCT05168176) | The Affiliated Hospital of Qingdao University | 2021-12-01 |
| Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT (NCT05095532) | Medical University of South Carolina | 2021-12-01 |
| A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML) (NCT05100303) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-12-01 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Potential Anti-tumor Effects of SSGJ-705 in Patients With Advanced or Metastatic HER2-expressing Solid Tumors (NCT05145179) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2021-12-01 |
| COVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines (NCT04845191) | ImmunityBio, Inc. | 2021-12-01 |
| Zinc Containing Vaginal Topical " Suppository " (NCT05453227) | Egymedicalpedia | 2021-12-01 |
| Universal Influenza A Vaccine in Healthy Adults (NCT05155319) | Emergent BioSolutions | 2021-12-01 |
| Effects of MDMA-like Substances in Healthy Subjects (NCT04847206) | University Hospital, Basel, Switzerland | 2021-12-01 |
| Acupuncture Combined With Mirabegron in the Treatment of OAB (NCT06181019) | The Affiliated Ganzhou Hospital of Nanchang University | 2021-12-01 |
| Effect of Alemtuzumab on Microglial Activation Positron Emission Tomography (PET) in Multiple Sclerosis (NCT03983252) | Brigham and Women's Hospital | 2021-12-01 |
| Impact of an Immune Modulator Dimethyl Fumarate on Acute Ischemic Stroke (NCT04890353) | Xuanwu Hospital, Beijing | 2021-12-01 |
| A Study of Orelabrutinib in Patients With ITP (NCT05124028) | Peking University People's Hospital | 2021-12-01 |
| Sirtuin-NAD Activator in Alzheimer's Disease (NCT05040321) | Brigham and Women's Hospital | 2021-12-01 |
| Study Evaluating Safety and Tolerability of Allocetra-OTS in Patients With COVID-19 (NCT04659304) | Enlivex Therapeutics Ltd. | 2021-12-01 |
| Clinical Comparison of Topical Application of Alvogyl Versus Hyaluronic-Acid Gel in Management of Pain And Palatal Wound Healing (NCT05334745) | Cairo University | 2021-12-01 |
| Orelabrutinib in Combination With Thiotepa in Refractory and Relapsed Primary CNS Lymphoma (NCT05021770) | Huiqiang Huang | 2021-12-01 |
| Clinical Trial of GAIA-102 for Advanced and Relapse NSCLC (NCT05207371) | GAIA BioMedicine Inc. | 2021-12-01 |
| Mindful Self-Compassion (MSC) for Infertility Related Distress (NCT05183568) | University of Regina | 2021-12-01 |
| Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 Infection (NCT04526717) | J Ints Bio | 2021-12-01 |
| Evaluating Intra-articular Injection of Axolotl Ambient Compared to Saline in Subjects With Ankle Osteoarthritis (NCT05092646) | Axolotl Biologix | 2021-12-01 |
| MSP3-CRM-Vac4All/ Alhydrogel® Malaria Vaccine (NCT05197751) | Vac4All | 2021-12-01 |
| Combination of the Immune Modulator Dimethyl Fumarate With Alteplase in Acute Ischemic Stroke (NCT04890366) | Xuanwu Hospital, Beijing | 2021-12-01 |
| A Study to Assess the Safety and Tolerability of E2511 in Healthy Adult and Elderly Participants (NCT05147337) | Eisai Inc. | 2021-12-01 |
| Minocycline for Chronic Autoimmune Uveitis (NCT05474729) | Sun Yat-sen University | 2021-12-01 |
| US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies (NCT04990323) | ExCellThera inc. | 2021-12-01 |
| A Phase Ⅰ Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine LYB001 (NCT05125926) | Yantai Patronus Biotech Co., Ltd. | 2021-12-01 |
| Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp (NCT05060237) | Biofrontera Bioscience GmbH | 2021-12-01 |
| A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101) (NCT05245968) | Taiho Pharmaceutical Co., Ltd. | 2021-12-01 |
| COVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines (NCT04843722) | ImmunityBio, Inc. | 2021-12-01 |
| PA3-17 Injection Treatment of Adult Patients With CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies (NCT05170568) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2021-12-01 |
| Pharmacokinetics of Oxycodone and PF614 Co-Administered with Nafamostat (PF614-MPAR-101) (NCT05090280) | Ensysce Biosciences | 2021-12-01 |
| Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy (NCT06074029) | Peking Union Medical College Hospital | 2021-12-01 |
| A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3811 Tablets in Patients With Advanced Malignant Tumors (NCT05046847) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-11-30 |
| A Study to Assess Relatlimab and Nivolumab Fixed-dose Combination in Chinese Participants With Advanced Solid Tumors (NCT05134948) | Bristol-Myers Squibb | 2021-11-30 |
| Clinical Trial to Assess Bioequivalence of Lazertinib Between Two Formulations in Healthy Volunteers. (NCT05162274) | Yuhan Corporation | 2021-11-30 |
| A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors (NCT05093322) | Hutchmed | 2021-11-30 |
| Mirabegron and Physiological Function in Cold Environments (NCT04766021) | Indiana University | 2021-11-30 |
| A Clinical Trial of XZP-6019 Tablets in Healthy Subjects (NCT05063968) | Xuanzhu Biopharmaceutical Co., Ltd. | 2021-11-30 |
| Hydroxychloroquine and Chlorphenesin Carbamate in Combination With mFOLFIRINOX in Pancreatic Cancer (NCT05083780) | Changhoon Yoo | 2021-11-30 |
| Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy Participants (NCT05166421) | AstraZeneca | 2021-11-30 |
| A Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic Amyloidosis (NCT05201911) | Attralus, Inc. | 2021-11-30 |
| An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC) (NCT05084261) | Adiso Therapeutics | 2021-11-30 |
| A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer (NCT05125016) | Regeneron Pharmaceuticals | 2021-11-30 |
| Effect of Low-dose 500 mg Abiraterone Acetate in Treatment of Metastatic Prostate Cancer Patients (NCT06193993) | National University Hospital, Singapore | 2021-11-30 |
| Effect of Anesthetics on Troponin I and С-reactive Protein (NCT05742789) | Astana Medical University | 2021-11-30 |
| Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis (NCT05199337) | K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. | 2021-11-30 |
| Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases (NCT04923542) | H. Lee Moffitt Cancer Center and Research Institute | 2021-11-30 |
| A Phase Ib/II Clinical Study of LBL-007 in Combination With Toripalimab in Treatment of Advanced Malignant Tumors (NCT05102006) | Nanjing Leads Biolabs Co.,Ltd | 2021-11-30 |
| DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies (NCT04895748) | Novartis Pharmaceuticals | 2021-11-30 |
| Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors (NCT05089266) | Shanghai Cell Therapy Group Co.,Ltd | 2021-11-30 |
| Randomized Clinical Trial: IS Zinc and Zinc Ionophere EGCG as Supplement Improve Outcome of Active Pulmonary Tuberculosis (NCT05116098) | Ministry of Health, Saudi Arabia | 2021-11-30 |
| A Study to Evaluate the Effect of Hepatic Impairment on Lazertinib (JNJ-73841937) (NCT05112952) | Janssen Research & Development, LLC | 2021-11-30 |
| Pinpoint Trial: Prebiotics IN Peanut Oral ImmunoTherapy (NCT05138757) | University of Chicago | 2021-11-30 |
| The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine (NCT05132855) | Chang Gung Memorial Hospital | 2021-11-30 |
| A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor (NCT05194982) | Sichuan Baili Pharmaceutical Co., Ltd. | 2021-11-29 |
| Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas (NCT04750928) | National Cancer Institute (NCI) | 2021-11-29 |
| Pharmacokinetic Study of a Fixed Dose Combination Nefopam Hydrochloride (30 mg) / Paracetamol (500 mg) (NCT05129137) | Unither Pharmaceuticals, France | 2021-11-29 |
| PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML (NCT05105152) | Seattle Children's Hospital | 2021-11-29 |
| A Study of Relative Bioavailability of a New Formulation Compared With the Approved Formulation of rhPTH [1-84] and to Find Out Dose Linearity of the New Formulation in Healthy Adults (NCT05137730) | Takeda | 2021-11-29 |
| A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal Impairment (NCT05198778) | JW Pharmaceutical | 2021-11-29 |
| Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma (NCT04572451) | Yana Najjar | 2021-11-29 |
| Phase 1 Study of BCD-245 in Subjects With Neuroblastoma (NCT05782959) | Biocad | 2021-11-29 |
| Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW (NCT06095362) | University Medical Center Groningen | 2021-11-29 |
| A Study of RC118 in Patients With Locally Advanced Unresectable/Metastatic Solid Tumours (NCT04914117) | RemeGen Co., Ltd. | 2021-11-29 |
| 68Ga-P16-093 PET/CT Imaging in Glioma Patients (NCT05569434) | Peking Union Medical College Hospital | 2021-11-28 |
| ARTEMIS-001: Phase 1 Study of the HS-20093 in Patients With Advanced Solid Tumors (NCT05276609) | Shanghai Hansoh Biomedical Co., Ltd | 2021-11-28 |
| Effect of Autologous Cord Blood-mononuclear Cells Infusion on Immune Microenvironment in Infants Born Very Preterm in NICU (NCT05087498) | Guangdong Women and Children Hospital | 2021-11-28 |
| A Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults (NCT05121506) | Gefion Canada Inc. | 2021-11-27 |
| Safety and Tolerability Study of Lu AG06466 in Healthy Young Japanese and Caucasian Participants (NCT05177029) | H. Lundbeck A/S | 2021-11-26 |
| A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Breast Cancer (NCT05160545) | Sichuan Baili Pharmaceutical Co., Ltd. | 2021-11-26 |
| Supplemental Oxygen in Hypovolemia (NCT05150418) | Oslo University Hospital | 2021-11-26 |
| Evaluation of the Tolerance, Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of MIL62 Injection for Treating Lupus Nephritis (NCT07044115) | Beijing Mabworks Biotech Co., Ltd. | 2021-11-26 |
| An Exploratory Clinical Study of BC006 in Patients With Advanced Solid Tumors (NCT05212896) | Dragonboat Biopharmaceutical Company Limited | 2021-11-26 |